HB-101

N/A

Report date: 2023/03/20 20:00:20

Base Information

Drug NameHB-101
Drug Alias NameVaxwaveHB-101
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRejection of renal transplantationCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNorway +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHookipa Biotech Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesHookipa Biotech Gmbh
Inactive CompaniesHookipa Pharma Inc
Active IndicationsRejection of renal transplantationCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A